FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912155459> ?p ?o ?g. }

• W2912155459 endingPage "61" @default.
• W2912155459 startingPage "53" @default.
• W2912155459 abstract "AimsThe primary aim was to compare 2 years of adjuvant tamoxifen versus no systemic treatment in premenopausal patients with oestrogen receptor (ER)–positive tumours, regarding breast cancer–free interval (BCFi) and distant recurrence–free interval (D-RFi), with 30 years of follow-up and for specified intervals. Moreover, we aimed to investigate the effects of adjuvant tamoxifen on the incidence of secondary malignancies and survival after distant recurrence.MethodsPremenopausal patients with primary breast cancer were randomised to 2 years of tamoxifen (n = 277) or no systemic treatment (n = 287), irrespective of ER status. Information regarding events was collected by a review of medical records and from national registers.ResultsThe median follow-up for all patients without events was 28 years, and only four of the patients alive had a follow-up of <20 years. With 30 years of follow-up, tamoxifen prolonged BCFi in the intention-to-treat population (hazard ratio [HR] = 0.76, 95% confidence interval (CI) 0.61–0.94, p = 0.011) compared with no treatment. In patients with ER-positive tumours (n = 362), tamoxifen prolonged BCFi (HR = 0.62, 95% CI 0.47–0.82, p = 0.001) and D-RFi (HR = 0.73, 95% CI 0.54–0.99, p = 0.043). The positive effect on BCFi was significant also for the interval >15–30 years (HR = 0.53, 95% CI 0.28–0.98, p = 0.042). For patients with ER-positive tumours who were diagnosed with distant recurrence (n = 165), survival after distant recurrence was shorter among tamoxifen-treated patients (median, 29 months versus 43 months). The incidence of contralateral breast cancer was 42% lower in the tamoxifen group (HR = 0.58, 95% CI 0.35–0.96, p = 0.035), whereas no differences were observed regarding other secondary malignancies.ConclusionsWith three decades of follow-up, 2 years of adjuvant tamoxifen reduced the incidence of breast cancer–related events and distant recurrence, and the carryover effect seems to extend beyond 15 years. Moreover, adjuvant tamoxifen seems to be associated with shorter survival after diagnosis of distant recurrence." @default.
• W2912155459 created "2019-02-21" @default.
• W2912155459 creator A5010340306 @default.
• W2912155459 creator A5012452403 @default.
• W2912155459 creator A5013487322 @default.
• W2912155459 creator A5018126939 @default.
• W2912155459 creator A5044198521 @default.
• W2912155459 creator A5044494492 @default.
• W2912155459 creator A5089541072 @default.
• W2912155459 date "2019-03-01" @default.
• W2912155459 modified "2023-10-14" @default.
• W2912155459 title "Effects of adjuvant tamoxifen over three decades on breast cancer–free and distant recurrence–free interval among premenopausal women with oestrogen receptor–positive breast cancer randomised in the Swedish SBII:2pre trial" @default.
• W2912155459 cites W1829077072 @default.
• W2912155459 cites W1865198604 @default.
• W2912155459 cites W1913585306 @default.
• W2912155459 cites W1988242406 @default.
• W2912155459 cites W1993686322 @default.
• W2912155459 cites W2029372507 @default.
• W2912155459 cites W2029636041 @default.
• W2912155459 cites W2096864872 @default.
• W2912155459 cites W2097216790 @default.
• W2912155459 cites W2118728607 @default.
• W2912155459 cites W2142408705 @default.
• W2912155459 cites W2161951565 @default.
• W2912155459 cites W2161977537 @default.
• W2912155459 cites W2358490704 @default.
• W2912155459 cites W2767600184 @default.
• W2912155459 cites W2886431125 @default.
• W2912155459 cites W4243828894 @default.
• W2912155459 doi "https://doi.org/10.1016/j.ejca.2018.12.034" @default.
• W2912155459 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30769227" @default.
• W2912155459 hasPublicationYear "2019" @default.
• W2912155459 type Work @default.
• W2912155459 sameAs 2912155459 @default.
• W2912155459 citedByCount "12" @default.
• W2912155459 countsByYear W29121554592020 @default.
• W2912155459 countsByYear W29121554592021 @default.
• W2912155459 countsByYear W29121554592022 @default.
• W2912155459 countsByYear W29121554592023 @default.
• W2912155459 crossrefType "journal-article" @default.
• W2912155459 hasAuthorship W2912155459A5010340306 @default.
• W2912155459 hasAuthorship W2912155459A5012452403 @default.
• W2912155459 hasAuthorship W2912155459A5013487322 @default.
• W2912155459 hasAuthorship W2912155459A5018126939 @default.
• W2912155459 hasAuthorship W2912155459A5044198521 @default.
• W2912155459 hasAuthorship W2912155459A5044494492 @default.
• W2912155459 hasAuthorship W2912155459A5089541072 @default.
• W2912155459 hasBestOaLocation W29121554591 @default.
• W2912155459 hasConcept C120665830 @default.
• W2912155459 hasConcept C121332964 @default.
• W2912155459 hasConcept C121608353 @default.
• W2912155459 hasConcept C126322002 @default.
• W2912155459 hasConcept C143998085 @default.
• W2912155459 hasConcept C207103383 @default.
• W2912155459 hasConcept C2777176818 @default.
• W2912155459 hasConcept C2777863537 @default.
• W2912155459 hasConcept C2908647359 @default.
• W2912155459 hasConcept C29456083 @default.
• W2912155459 hasConcept C44249647 @default.
• W2912155459 hasConcept C50382708 @default.
• W2912155459 hasConcept C530470458 @default.
• W2912155459 hasConcept C61511704 @default.
• W2912155459 hasConcept C71924100 @default.
• W2912155459 hasConcept C99454951 @default.
• W2912155459 hasConceptScore W2912155459C120665830 @default.
• W2912155459 hasConceptScore W2912155459C121332964 @default.
• W2912155459 hasConceptScore W2912155459C121608353 @default.
• W2912155459 hasConceptScore W2912155459C126322002 @default.
• W2912155459 hasConceptScore W2912155459C143998085 @default.
• W2912155459 hasConceptScore W2912155459C207103383 @default.
• W2912155459 hasConceptScore W2912155459C2777176818 @default.
• W2912155459 hasConceptScore W2912155459C2777863537 @default.
• W2912155459 hasConceptScore W2912155459C2908647359 @default.
• W2912155459 hasConceptScore W2912155459C29456083 @default.
• W2912155459 hasConceptScore W2912155459C44249647 @default.
• W2912155459 hasConceptScore W2912155459C50382708 @default.
• W2912155459 hasConceptScore W2912155459C530470458 @default.
• W2912155459 hasConceptScore W2912155459C61511704 @default.
• W2912155459 hasConceptScore W2912155459C71924100 @default.
• W2912155459 hasConceptScore W2912155459C99454951 @default.
• W2912155459 hasFunder F4320312350 @default.
• W2912155459 hasFunder F4320321491 @default.
• W2912155459 hasFunder F4320321929 @default.
• W2912155459 hasFunder F4320322790 @default.
• W2912155459 hasFunder F4320335417 @default.
• W2912155459 hasLocation W29121554591 @default.
• W2912155459 hasLocation W29121554592 @default.
• W2912155459 hasOpenAccess W2912155459 @default.
• W2912155459 hasPrimaryLocation W29121554591 @default.
• W2912155459 hasRelatedWork W1771722205 @default.
• W2912155459 hasRelatedWork W2015092588 @default.
• W2912155459 hasRelatedWork W2027175481 @default.
• W2912155459 hasRelatedWork W2057553101 @default.
• W2912155459 hasRelatedWork W2119154902 @default.
• W2912155459 hasRelatedWork W2133235702 @default.
• W2912155459 hasRelatedWork W2172254302 @default.
• W2912155459 hasRelatedWork W2203903734 @default.
• W2912155459 hasRelatedWork W2464051959 @default.

• next